About Alberto Serrano Pozo, MD, PhD
Dr. Serrano-Pozo is originally from Málaga, Spain. He received his MD in 2001 at the University of Málaga School of Medicine and completed his neurology residency in 2006 at the University Hospital Virgen del Rocío in Seville (Spain), followed by a 2-year research and behavioral neurology fellowship at the same institution. He first joined Dr. Bradley Hyman’s lab at MGH as a research fellow in 2008, where he investigated clinic-pathological correlations of Alzheimer’s dementia using brain specimens from the Massachusetts Alzheimer’s Disease Research Center brain bank, as well as the National Alzheimer’s Coordinating Center (NACC) database. His publications during this period resulted in Dr. Serrano-Pozo obtaining his PhD at the University of Seville in 2013. Next, he pursued a US neurology residency, which he completed at the University of Iowa in 2017 as Chief Resident. He then returned to MGH to complete a Clinical Dementia fellowship and pursue his career as clinician-scientist in the field of Alzheimer's disease and related dementias.
Clinical Interests:
- Alzheimer's Disease
- Cognitive/behavioral neurology
- Dementia
- Dementia with lewy bodies
- Frontotemporal Dementia
- Memory disorders
Treats:
- Adult
Languages:
- Spanish
Locations
Mass General Neurology
55 Fruit St.
Boston, MA 02114
Phone: 855-644-6387
Medical Education
- MD, University of Malaga-Spain
- Residency, University Hospital Spain
- Residency, University of Iowa Hospital & Clinics
- Fellowship, Massachusetts General Hospital
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
I am a clinician-scientist neurologist with interest in Alzheimer’s disease and other neurodegenerative dementias. My research focuses on trying to explain how the amyloid plaques and neurofibrillary tangles accumulate in the brain of Alzheimer’s disease patients and how they lead to dementia. I first approached this question by studying postmortem brain specimens from Alzheimer’s disease patients and healthy individuals under the microscope. The findings of my unbiased quantitative analyses supported an important role of glial (non-neuronal) cells, specifically astrocytes and microglial cells. These cells clearly react to plaques and tangles, but the consequences of this response remain largely unknown. Therefore, I became interested in understanding the underlying mechanisms of glial responses and their effects on Alzheimer’s disease development and progression.
Publications
-
Selected publications:
- Qian J, Betensky RA, Hyman BT, Serrano-Pozo A. Association of APOE genotype with heterogeneity of cognitive decline rate in Alzheimer’s disease. Neurology 2021 (in press).
- Escartin C*, Galea E*, Lakatos A**, O’Callaghan J**, Petzold G**, Serrano-Pozo A**, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 2021; 24(5): 312-25.
- Noori A, Mezlini AM, Hyman BT, Serrano-Pozo A*, Das S*. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration. Neurobiol Dis 2021; 149: 105225.
- Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 2021; 20(1): 68-80.
- Das S*, Li Z*, Noori A, Hyman BT, Serrano-Pozo A. Meta-analysis of mouse transcriptomic studies supports a context-dependent astrocyte reaction in acute CNS injury versus neurodegeneration. J Neuroinflammation 2020; 17(1): 227.
- Gui Y, Marks JD, Das S, Hyman BT, Serrano-Pozo A. Characterization of the 18 kDa translocator protein (TSPO) in post-mortem normal and Alzheimer’s brains. Brain Pathol 2020; 30(1): 151-164.
Dr. Serrano Pozo has always been incredibly professional, respectful. I've been very impressed that he is always prepared and has done his research on my father's history, read records and notes prior to us coming in, so he doesn't ask questions that he could get from our files. And he has been incredibly responsive in terms of calling me back ... Read More
Dr Serrano Pozo was excellent; he was familiar with the records and very helpful.
excellent physician
I have high respect and great regard for this doctor. So I give him a top grade.
Yes, we were very pleased with Dr. Pozo, and his professionalism, his insight, and just knowledge of his discipline, and also of the situation, the characteristics, and the things that he needs to look at with [redacted], and things in the future that need to be tested.
I liked it very much. I got what I needed to know. My husband was with me. And I thank you very much.
shows concern for my wellbeing
He takes time with me and listens to everything I have to say. He's very encouraging. I appreciate that.
Dr. Serrano Pozo offers a wonderful feeling of support and compassion, but we remain frustrated that there has not been a clear path forward nor a discussion of what the future looks like- trajectory, manor of decline and the likely timeframe for increasing levels of care.
Dr Serrano Pozo is excellent, knowledgeable, caring and a great professional.